Long non-coding RNA X-inactive-specific transcript contributes to cisplatin resistance in gastric cancer by sponging

Xiao Han1, Hai-Bin Zhang, Xue-Di Li

  • 1Internal Medicine-Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.

Anti-Cancer Drugs
|October 3, 2020
PubMed

Insights

X-inactive-specific transcript (XIST) is overexpressed in gastric cancer, promoting cisplatin resistance. This oncogenic noncoding RNA interacts with Let-7b-5p, impacting cancer cell survival and treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • X-inactive-specific transcript (XIST) is a 19 kb noncoding RNA with oncogenic roles in various cancers, including gastric cancer.
  • XIST is implicated in cisplatin resistance in gastric cancer cells, but the underlying mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the role of XIST in gastric cancer and its contribution to cisplatin resistance.
  • To identify potential molecular interactions involving XIST in gastric cancer.

Main Methods:

  • Quantification of XIST levels in gastric cancer cells and patient tumor specimens.
  • Bioinformatic prediction and experimental validation of microRNA interactions with XIST.
  • Assessment of the impact of XIST and microRNA modulation on gastric cancer cell behavior and gene expression.

Main Results:

  • XIST is overexpressed in gastric cancer cells and tumors, correlating with poor patient prognosis.
  • High XIST levels are associated with increased cisplatin resistance in gastric cancer cells.
  • Let-7b-5p was identified as a direct interaction partner of XIST, with an inverse correlation in tumor tissues.
  • Modulation of Let-7b-5p partially rescued the effects of XIST knockdown on cell proliferation and apoptosis via Aurora kinase B regulation.

Conclusions:

  • XIST acts as an oncogene in gastric cancer, conferring cisplatin resistance through its interaction with Let-7b-5p.
  • The XIST/Let-7b-5p axis represents a potential therapeutic target for overcoming cisplatin resistance in gastric cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.2K
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
7.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.0K